No Data
No Data
Xinlong Holding: 2025 First Quarter Report
Xinlong Holding(Group)Company (000955.SZ): A net loss of 0.9377 million yuan in the first quarter.
On April 23, Glonghui reported that Xinlong Holding(Group)Company (000955.SZ) announced its Q1 2025 report, with revenue of 99.4655 million yuan, a year-on-year decrease of 7.44%; the net income attributable to shareholders of the listed company was -0.9377 million yuan; the net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was -2.9692 million yuan; the basic EPS was -0.0017 yuan.
Xinlong Holdings: 2024 Annual Report Summary
Xinlong Holdings: 2024 Annual Report
Xinlong Holding(Group)Company (000955.SZ): Net loss of 16.6127 million yuan for the 2024 fiscal year.
Gelonghui, April 2nd丨Xinlong Holding(Group)Company (000955.SZ) announced its annual report for 2024, with the company achieving revenue of 0.523 billion yuan, a year-on-year decrease of 11.53%; the net income attributable to shareholders of the listed company was -16.6127 million yuan; the net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was -21.6114 million yuan; the basic EPS was -0.0309 yuan.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.